Serial Number | 79339429 |
Word Mark | NYJANBA |
Filing Date | Thursday, March 10, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 25, 2022 |
Registration Number | 6882155 |
Registration Date | Tuesday, October 25, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 9, 2022 |
Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
Translation of Words in Mark | The wording ¿NYJANBA¿ has no meaning in a foreign language. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, May 10, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Novartis AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Party Name | Novartis AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Party Name | Novartis AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Event Date | Event Description |
Tuesday, March 14, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Saturday, February 18, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, February 17, 2023 | FINAL DISPOSITION PROCESSED |
Wednesday, January 25, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, October 25, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, October 25, 2022 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, August 9, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 9, 2022 | PUBLISHED FOR OPPOSITION |
Monday, August 8, 2022 | REFUSAL PROCESSED BY IB |
Wednesday, July 20, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, July 11, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, July 11, 2022 | REFUSAL PROCESSED BY MPU |
Thursday, July 7, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, July 7, 2022 | EXAMINER'S AMENDMENT ENTERED |
Thursday, July 7, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, July 7, 2022 | EXAMINERS AMENDMENT E-MAILED |
Thursday, July 7, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, July 7, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, July 6, 2022 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Wednesday, July 6, 2022 | PRIORITY ACTION E-MAILED |
Wednesday, July 6, 2022 | PRIORITY ACTION WRITTEN |
Tuesday, July 5, 2022 | ASSIGNED TO EXAMINER |
Monday, June 20, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Monday, June 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, June 20, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Monday, June 20, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Monday, June 20, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, June 20, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Saturday, May 14, 2022 | APPLICATION FILING RECEIPT MAILED |
Tuesday, May 10, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, May 9, 2022 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Thursday, April 28, 2022 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |